{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-228064","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2022-08-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.591330+00:00","generated_at":"2026-06-23T21:52:14.129282+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Integra LifeSciences voluntarily recalls all CereLink ICP monitors; cuts guidance by $9M","bullets":["Voluntary global removal of all CereLink intracranial pressure monitors due to out-of-range readings from electrical interference.","Records $9M returns provision in Q3 2022; Q3 revenue guidance lowered to $374-382M from $383-391M.","Full-year revenue guidance reduced to $1,548-1,566M from $1,557-1,575M; adjusted EPS lowered to $3.12-3.20 from $3.21-3.29.","Low incidence rate at limited sites; investigation ongoing; plans to resume shipments after resolution."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-228064","json":"https://secwatch.observer/filing/0001193125-22-228064.json","markdown":"https://secwatch.observer/filing/0001193125-22-228064.md","text":"https://secwatch.observer/filing/0001193125-22-228064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/0001193125-22-228064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/d366857d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:52:14.129282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}